| Code | CSB-MP009438RA1 |
| Abbreviation | Recombinant Rat Gipr protein, partial (Active) |
| MSDS | |
| Size | $256 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
GIPR mediates the insulinotropic effects of glucose-dependent insulinotropic polypeptide and represents a key target in metabolic disease research, yet studying its extracellular domain in isolation requires a system that preserves native glycosylation and disulfide architecture. This mammalian-expressed fragment spanning residues 19–135 captures the ligand-binding domain and demonstrates quantifiable binding activity in functional ELISA, achieving an EC50 of 26.97–33.90 ng/mL when immobilized at 2 μg/mL against a recombinant anti-GIPR antibody. The validated binding kinetics support its use in competitive inhibition assays, therapeutic antibody epitope mapping, and screening campaigns for biologics or small molecules targeting the GIP signaling axis. With purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg, this protein meets the quality thresholds commonly required for SPR-based affinity characterization, biolayer interferometry, and antibody validation workflows in obesity and diabetes research.
There are currently no reviews for this product.